Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

EMMAC Life Sciences

EMMAC Life Sciences
2018 FOUNDED
PRIVATE STATUS
Debt LATEST DEAL TYPE
$18.6M LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of medical cannabis products intended to bring together cutting-edge scientific research with the latest innovations based in London, United Kingdom. The company uses the latest science and research with cutting-edge cultivation, extraction and production techniques, enabling clients to directly treat patients with chronic pain, spasticity and cancer.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Primary Office
  • Gilmoora House
  • 57-61 Mortimer Street
  • London W1W 8HS
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore EMMAC Life Sciences’s full profile, request a free trial.

EMMAC Life Sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - General 16-Oct-2019 $18.6M 000.00 Completed Generating Revenue
3. Early Stage VC 13-Jun-2019 000.00 000.00 00000 Completed Generating Revenue
2. Early Stage VC 08-Mar-2019 $14.3M $22.1M 00000 Completed Startup
1. Early Stage VC 06-Feb-2019 $7.79M $7.79M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

EMMAC Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 92,000,000 $0.001270 $0.01 $0.01 1x $0.01 31.72%
Ordinary 130,000,000 $0.001270 $0.01 $0.01 1x $0.01 44.83%
To view this company’s complete Cap Table, request access »

EMMAC Life Sciences Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000 (00000 16-Jul-2019 000000000000000000 Cultivation 0000000 00000000
0000000 0000 09-Jul-2019 00000 0000000 Drug Discovery 0000000 00000000
00000 0000 0000000 11-Jun-2019 000000000000000000 Other Consumer Non-Durables 0000000 00000000
0000000 0000000000 09-Apr-2019 000000000000000000 Pharmaceuticals 0000000 00000000
Blossom Swiss 29-Jan-2019 Merger/Acquisition Pharmaceuticals 0000000 00000000
To view this company’s complete investment and acquisition history, request access »

EMMAC Life Sciences Subsidiaries (4)

Company Name Industry Location Founded
Green Leaf Company Other Consumer Non-Durables Sannois, France 2017
0000000 00000 Pharmaceuticals Switzerland 0000
0000000 0000000000 Pharmaceuticals Sunderland, United Kingdom 0000
0000000000 Discovery Tools (Healthcare) Alicante, Spain 0000
To view this company’s complete subsidiary history, request access »

EMMAC Life Sciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Altitude Investment Management Venture Capital Minority 000 0000 000000 0
Fountain Healthcare Partners Venture Capital Minority 000 0000 000000 0
FastForward Innovations Venture Capital Minority 000 0000 000000 0

EMMAC Life Sciences Executive Team (3)

Name Title Board
Seat
Contact
Info
Antonio Costanzo Chief Executive Officer & Co-Founder
Barbara Pacchetti Chief Scientific Officer & Executive Director
Thomas Ellen Director, Finance & Board Member

EMMAC Life Sciences Board Members (2)

Name Representing Role Since Contact
Info
Thomas Ellen EMMAC Life Sciences Director, Finance & Board Member 000 0000
Tom Rooke EMMAC Life Sciences Non-Executive Chairman 000 0000